These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 18052990

  • 1. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
    Béquet F, Uzabiaga F, Desbazeille M, Ludwiczak P, Maftouh M, Picard C, Scatton B, Le Fur G.
    Eur J Neurosci; 2007 Dec; 26(12):3458-64. PubMed ID: 18052990
    [Abstract] [Full Text] [Related]

  • 2. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
    Mulè F, Amato A, Baldassano S, Serio R.
    Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
    [Abstract] [Full Text] [Related]

  • 3. Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice.
    Gomes FV, Casarotto PC, Resstel LB, Guimarães FS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):434-8. PubMed ID: 21111767
    [Abstract] [Full Text] [Related]

  • 4. Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.
    Hampson RE, Miller F, Palchik G, Deadwyler SA.
    Neuropharmacology; 2011 May 30; 60(6):944-52. PubMed ID: 21288475
    [Abstract] [Full Text] [Related]

  • 5. O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus.
    Jergas B, Schulte K, Bindila L, Lutz B, Schlicker E.
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul 30; 387(7):621-8. PubMed ID: 24853577
    [Abstract] [Full Text] [Related]

  • 6. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M, Petrosino S, Guglielmotti V, Rossi F, Di Marzo V.
    J Pharmacol Exp Ther; 2006 Mar 30; 316(3):969-82. PubMed ID: 16284279
    [Abstract] [Full Text] [Related]

  • 7. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA, Kaiser N, Monory K, Lutz B.
    Neuropharmacology; 2008 Jan 30; 54(1):141-50. PubMed ID: 17709120
    [Abstract] [Full Text] [Related]

  • 8. Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.
    Ho WS, Gardiner SM.
    Br J Pharmacol; 2009 Jan 30; 156(1):94-104. PubMed ID: 19133994
    [Abstract] [Full Text] [Related]

  • 9. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
    Fidelman S, Mizrachi Zer-Aviv T, Lange R, Hillard CJ, Akirav I.
    Eur Neuropsychopharmacol; 2018 May 30; 28(5):630-642. PubMed ID: 29519609
    [Abstract] [Full Text] [Related]

  • 10. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats.
    Hasanein P, Teimuri Far M.
    Pharmacol Biochem Behav; 2015 Apr 30; 131():130-5. PubMed ID: 25689415
    [Abstract] [Full Text] [Related]

  • 11. Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus.
    Di S, Boudaba C, Popescu IR, Weng FJ, Harris C, Marcheselli VL, Bazan NG, Tasker JG.
    J Physiol; 2005 Dec 15; 569(Pt 3):751-60. PubMed ID: 16239276
    [Abstract] [Full Text] [Related]

  • 12. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
    Shivachar AC.
    Biochem Pharmacol; 2007 Jun 15; 73(12):2004-11. PubMed ID: 17445778
    [Abstract] [Full Text] [Related]

  • 13. CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats.
    Rubio M, Fernández-Ruiz J, de Miguel R, Maestro B, Michael Walker J, Ramos JA.
    Neuropharmacology; 2008 May 15; 54(6):976-88. PubMed ID: 18371990
    [Abstract] [Full Text] [Related]

  • 14. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
    Gómez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, Rodríguez de Fonseca F.
    J Neurosci; 2002 Nov 01; 22(21):9612-7. PubMed ID: 12417686
    [Abstract] [Full Text] [Related]

  • 15. Anandamide inhibits transport-related oxygen consumption in the loop of Henle by activating CB1 receptors.
    Silva GB, Atchison DK, Juncos LI, García NH.
    Am J Physiol Renal Physiol; 2013 Feb 15; 304(4):F376-81. PubMed ID: 23220721
    [Abstract] [Full Text] [Related]

  • 16. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses.
    Kim J, Alger BE.
    Nat Neurosci; 2010 May 15; 13(5):592-600. PubMed ID: 20348918
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619.
    Hillard CJ, Ho WS, Thompson J, Gauthier KM, Wheelock CE, Huang H, Hammock BD.
    Br J Pharmacol; 2007 Nov 15; 152(5):691-8. PubMed ID: 17891162
    [Abstract] [Full Text] [Related]

  • 18. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F, Amato A, Baldassano S, Serio R.
    Pharmacol Res; 2007 Sep 15; 56(3):185-92. PubMed ID: 17656103
    [Abstract] [Full Text] [Related]

  • 19. Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages.
    Jiang LS, Pu J, Han ZH, Hu LH, He B.
    Cardiovasc Res; 2009 Mar 01; 81(4):805-13. PubMed ID: 19074161
    [Abstract] [Full Text] [Related]

  • 20. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
    Lisboa SF, Gomes FV, Silva AL, Uliana DL, Camargo LH, Guimarães FS, Cunha FQ, Joca SR, Resstel LB.
    Int J Neuropsychopharmacol; 2015 Jan 24; 18(8):. PubMed ID: 25618404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.